TONIX PHARMACEUTICALS HOLDING CORP. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate of 2.19% for the 3-month period ending 2014-03-31, per its 10-Q filed 2015-05-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate · last filed 2016-03-03
- TONIX PHARMACEUTICALS HOLDING CORP. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for the quarter ending 2014-03-31 was 2.19%, a 8.42% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for the quarter ending 2013-03-31 was 2.02%.
- TONIX PHARMACEUTICALS HOLDING CORP. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for fiscal 2013 was 2.02%, a 8.02% increase from fiscal 2012.
- TONIX PHARMACEUTICALS HOLDING CORP. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for fiscal 2012 was 1.87%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 12 month |
|---|---|---|---|---|
| 2014-03-31 | 2.19% 10-Q · filed 2015-05-08 | |||
| 2013-12-31 | 2.02% 10-K · filed 2016-03-03 | |||
| 2013-09-30 | 2.02% 10-Q · filed 2014-11-07 | |||
| 2013-06-30 | 2.02% 10-Q · filed 2014-08-08 | |||
| 2013-03-31 | 2.02% 10-Q · filed 2014-05-13 | |||
| 2012-12-31 | 1.87% 10-K · filed 2014-03-28 | |||
| 2012-09-30 | 1.87% 10-Q · filed 2012-11-14 | |||
| 2012-06-30 | 1.87% 10-Q · filed 2012-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |